Skip to main content

Asthma News

Asthma News - April 9, 2026

Current asthma research, announcements and opportunities, collected and distributed by Michigan Department of Health & Human Services (MDHHS) Asthma Program Staff. Sign up to receive weekly-ish news emails at MDHHS-Asthma@michigan.gov

Check out the most recent MDHHS asthma social media messages and share them with your networks.

Parents Against Vaping (PAVe) Webinar: From Classrooms to Communities: The Impact of Vape Waste ~ April 21 @ 6 PM ET

As nicotine products become more addictive, discreet, and widely used by young people, disposable e-cigarettes are driving two connected harms: rising youth addiction and a surge in toxic waste. The discussion will be grounded in current experiences, featuring a school superintendent and members of PAVe’s Youth Advisory Board.

Allergy & Asthma Network: Understanding Chronic Cough

A chronic cough is one that lasts 8 weeks or more in adults and 4 weeks or more in children. It can cause headaches, disrupt sleep and daily activities, and lead to lung damage. Many conditions can cause chronic cough, including asthma, postnasal drip and gastroesophageal reflux disease (GERD). When should someone with a chronic cough see their doctor about it?

MI Asthma Research Website, Seeking Research Participants

The MI Asthma Research team is here to support the efforts of providers and participants through our severe asthma research studies. Learn more about Michigan Medicine studies, progress, and stories from people who have made positive steps towards asthma control, and how you can help advance asthma health care, by visiting the MI Asthma Research website.

Serum Midkine as a Potential Biomarker Associated with Disease Severity and Remodeling-Related Mediators in Children with Asthma

Serum midkine levels were significantly higher in children with asthma than in healthy controls and increased progressively with disease severity. Serum midkine levels were negatively correlated with lung function parameters and positively correlated with eosinophilia, total immunoglobulin E (IgE), fractional exhaled nitric oxide (FeNO), pro-inflammatory cytokines, and remodeling-related mediators.

Fracture Risk Among Pediatric Asthma Patients Treated With Inhaled Corticosteroids (ICS): A Retrospective Cohort Study

ICS use, alone or with long-acting beta-2 agonists (LABA), was not associated with increased fracture risk and may offer modest skeletal protection. These findings support the safety of early ICS incorporation in pediatric asthma regimens and reinforce international recommendations moving away from short-acting beta-2 agonist (SABA) monotherapy.

Impact of Dupilumab for Severe Asthma on Fatigue, Quality of Life, Work Productivity, and Activity

In this real-world large cohort study, fatigue, quality of life, work productivity, and activity impairment improved following dupilumab initiation, which was associated with improved asthma symptom control. However, many patients remained impaired in these outcomes after 12 months.